User profiles for David S Khoury
David KhouryKirby Institute Verified email at unsw.edu.au Cited by 8686 |
[HTML][HTML] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …
correlates of protection to assist in the future deployment of vaccines. To address this, we …
[HTML][HTML] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
[HTML][HTML] Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease. However, …
vaccines are highly effective at preventing infection and especially severe disease. However, …
[HTML][HTML] Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Background Several SARS-CoV-2 variants of concern have been identified that partly escape
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
[HTML][HTML] Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Vaccine protection from symptomatic SARS-CoV-2 infection has been shown to be strongly
correlated with neutralising antibody titres; however, this has not yet been demonstrated for …
correlated with neutralising antibody titres; however, this has not yet been demonstrated for …
[HTML][HTML] Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement. …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement. …
[PDF][PDF] Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
…, DS Khoury, S Gouma, P Hicks, S Dysinger… - Cell, 2022 - cell.com
We examined antibody and memory B cell responses longitudinally for ∼9–10 months after
primary 2-dose SARS-CoV-2 mRNA vaccination and 3 months after a 3rd dose. Antibody …
primary 2-dose SARS-CoV-2 mRNA vaccination and 3 months after a 3rd dose. Antibody …
[HTML][HTML] Predicting the efficacy of variant-modified COVID-19 vaccine boosters
Booster vaccination for the prevention of Coronavirus Disease 2019 (COVID-19) is required
to overcome loss of protection due to waning immunity and the spread of novel severe acute …
to overcome loss of protection due to waning immunity and the spread of novel severe acute …